DOCSLIB.ORG

Xanthomonas Citri Pv. Malvacearum) Prevalence in Western Kenya

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Xanthomonas Citri Pv. Malvacearum) Prevalence in Western Kenya “Survival for the fittest of a species is the total sum effect of accumulated variation produced in each generation better adapted to the environment” Charles Darwin (1809-1882) i Promotors: Prof. Dr. ir. Geert Haesaert Department of Applied Bioscience Engineering, Faculty of Bioscience Engineering, Ghent University, Belgium Prof. Dr. Godelieve Gheysen Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium Chairman of examination committee Prof. dr. Colin Janssen Department of Applied Ecology & Environmental Biology, Ghent University Members of the reading committee Prof. dr. ir. Patrick Van Damme Faculty of Bioscience Engineering, Ghent University Prof. Dr. ir. Monica Höfte Faculty of Bioscience Engineering, Ghent University Dr. ir. Bart Cottyn Instituut voor Landbouwen Visserijonderzoek (ILVO) Dr. Danny Vereecke Department of Plant Production University College Ghent Prof. Dr. Sabastian Masaert Unite de phytopathology, Gembloux Dean: Prof. Dr. ir. Marc Van Meirvenne Rector: Prof. Dr. Anne De Paepe ii Kennedy Chepkurui Pkania Genetic diversity of cotton and bacterial blight (Xanthomonas citri pv. malvacearum) prevalence in Western Kenya Thesis submitted in fulfillment of the requirement for the degree of Doctor (PhD) of Applied Biological Sciences: Agricultural Sciences iii Dutch translation of the title: Genetische diversiteit van katoen en ras specificiteit van Xanthomonas citri pv. malvacearum in West Kenia Illustration on the cover: Cotton field ready for harvest Please refer to this work as follows: Pkania C.K. (2016). Genetic diversity of cotton and bacterial blight (Xanthomonas citri pv. malvacearum) prevalence in Western Kenya. PhD Thesis, Ghent University, Belgium ISBN-number: 978-90-5989-924-7 The research was financially supported by Moi University VLIR–UOS (Flemish Interuniversity Council - department for University Cooperation for Development) project activity funds The author and the promoters give the authorization to consult and to copy parts of this work for personal use only. Every other use is subject to the copyright laws. Permission to reproduce any material contained in this work should be obtained from the author. iv ACKNOWLEDGEMENT In 2010, I arrived at Ghent University to enroll for my PhD studies and as I come close to its completion. I would not have reached this level without the contribution of the many people who held my hand in this tremendous journey and have had so much influence to the work. I would like to express my sincere gratitude to my doctoral promoter Prof. Dr. ir. Geert Haesaert for the incredible guidance you provided throughout my doctoral study at the Department of Applied Bioscience Engineering, Faculty of Bioscience Engineering, Ghent University, Belgium. The many consultations you accorded me to ensure that nothing went wrong during my study stay surely I have no words to express it but accept my sincere appreciation that without your expert guidance this journey would have surely been tough. I also wish to thank my co-promoter Prof. Dr. Godelieve Gheysen for your valuable suggestions, useful comments and expert advice throughout project formulation; implementation to this final stage of thesis submission, surely this work would not have been possible without you. The constant availability and guidance whenever an issue arose provided me enormous opportunity to proceed with the research in a focused manner throughout the period. Sincere gratitude goes to Prof. Dr. ir. Kris Audenaert for the unlimited access you accorded me on the many issues especially many molecular applications, statistical and review work of my study that enabled me to undertake successful molecular work despite my previous limited experience. You were always ready to troubleshoot for me whenever I got stuck and your guidance on data analysis will forever be remembered. I greatly thank ir. Jolien Venneman for everything we have gone through together in the course of my study. We met the first time as a Master’s thesis student on research travel grant to Kenya. I was lucky to supervise a very hardworking student who adapted very fast to the new environment. I remember the field work we carried out together in hot tropical conditions when temperature exceeded 30°C and an almost 100% humidity but you never complained but you always remained focused on the objective. The field evaluations, sample collection in Kenya and laboratory work in Ghent and tropical greenhouse in Melle. The manner in which we worked together will forever remain in my mind based on commitment that you put in to ensure all went well. The academic partnership that has existed from the first day we met is unmatched. I cannot enumerate all but overall thanks for everything and I trust the future holds a lot of hope for you in the academic field and my prayer is that God almighty will bless you abundantly. v Special thanks to all my colleagues at Faculty of Bioscience Engineering, Department of Applied Biological Science Ghent University; Prof. Dr. Geert Baert, Dr. ir. Frank Wesbrouck, Jolien Miclotte, Sophy Aschoot, Marelke, Boris, etc.; the friendly environment was just wonderful for academic growth. The long list of people who assisted me can not be exhausted without mentioning the following people who helped me in many ways at the University of Eldoret (UOE), Kenya: Dr. O.K. Kiplagat HOD Biotechnology department at UOE - Kenya, VLIR–UOS AGBIO Team leader Dr. Florence Wamunga and all team members: Prof. Dr. Okalebo, Prof. Dr. Auma, Dr. Ngode, Prof. Dr. Gohole, Dr. Nekesa, Mr. Katloi, Mr. Rugut, Mr. Njira, Mrs. Njoroge, and Mrs. Emmy Chepkoech to mention only a few and all UOE community for the conducive environment you provided for my study. I will not forget my friend and colleague Mr. Moses Kiniga (Field Officer Biotechnology Department UOE) for your effort to ensure that the greenhouse and experimental fields were well-maintained even in my absence, thanks very much and may God bless you. Special thanks I wish to extend to my parents; my dad Mr. John T. Kiboi, and Mum Mrs. Rebecca N. Pkania for the value of education you accorded me despite not having the formal education. The Christian upbringing and focused approach to life you always inculcate on me since my childhood has played a tremendous role in my academic life. I will not forget my whole extended family for which I can not mention everyone: brothers, sisters, cousins and friends. All of you have made me what I am. I wish to pay special tribute to my dear family: my dear wife Eunice K. Pkania, children: Delphine, Newton, Madeleine, Iverson, and Herbert, your cousins Winnie, Yvonne and Aunt Millie. To my wife Mrs. Eunice K. Pkania, your constant love, encouragement and support will be remembered forever. My dear Eunice, you have been a major inspiration playing both roles as mother and father for our kids to an extent they seem to have not even felt my absence during my stay in Belgium. This study would not have been completed without you. To my children and entire household my prayer to the Lord almighty is that He will shower special blessings on you for the respect and discipline you displayed throughout. You remain my dream and motivation for what the future hold and my prayers are always upon you. Last but not least, special thanks go to Moi University VLIR–UOS project for awarding me the scholarship to undertake my doctoral studies at Ghent University and University of Eldoret (UOE) on sandwich. vi Finally, my very sincere thanks go to the “Almighty Father” in heaven for bringing me this far in life. Lord almighty you have guided my destiny since my childhood and I believe I would not have reached this level without you and I pray that you’ll continue to guide me in all future endeavours. Thank you all and God bless. vii TABLE OF CONTENTS ACKNOWLEDGEMENT ............................................................................................................................ v LIST OF ABBREVIATIONS ....................................................................................................... xii CHAPTER 1 ................................................................................................................................... 1 INTRODUCTION, PROBLEM STATEMENT, OBJECTIVES AND OUTLINE ................................. 1 1.1. INTRODUCTION ........................................................................................................................ 2 1.2. PROBLEM STATEMENT AND JUSTIFICATION ................................................................... 5 1.3. RESEARCH OBJECTIVES ......................................................................................................... 8 1.4. THESIS OUTLINE ....................................................................................................................... 9 CHAPTER 2: LITERATURE REVIEW ...................................................................................... 11 BIOLOGY OF COTTON, GENETIC DIVERSITY AND BACTERIAL BLIGHT DISEASE ............ 11 2.1 ORIGIN AND PRE-HISTORIC COTTON UTILISATION ...................................................... 11 2.2 TAXONOMY AND DISTRIBUTION OF COTTON ............................................................... 11 2.2.1 Taxonomy and evolution of the commercial Gossypium species ....................................... 11 2.2.2 Current production and geographical distribution .............................................................. 13 2.3 BIOLOGY OF COTTON ..........................................................................................................
Load more

Recommended publications
  • Common Bacterial Blight (Xanthomonas Axonopodis Pv
    atholog P y & nt a M Belete and Bastas, J Plant Pathol Microbiol 2017, 8:3 l i P c f r o o b DOI: 10.4172/2157-7471.1000403 l i Journal of a o l n o r g u y o J ISSN: 2157-7471 Plant Pathology & Microbiology Review Article Article Open Access Common Bacterial Blight (Xanthomonas axonopodis pv. phaseoli) of Beans with Special Focus on Ethiopian Condition Belete T1* and Bastas KK2 1Department of Plant Sciences and Horticulture, College of Dry Land Agriculture, Samara University, Samara, Ethiopia 2Department of Plant protection, Faculty of Agriculture, Selcuk University, Campus/Konya, Turkey Abstract Common bacterial blight (CBB) is the most devastating factor that affects common bean crops in all common bean growing areas. This review was to review with an objective of reviewing the biology, economic importance of CBB of common bean crop disease and its management options, with an emphasis on the future research direction and priorities. CBB disease, caused by the gram-negative bacterial pathogen Xanthomonas axonopodis pv. phaseoli (Xap) and its fuscans variant Xanthomonas fuscans subsp. fuscans (Xff) is the major bottleneck in bean production in the world as well as in Ethiopia. It is a serious bacterial disease of common bean which causes lesions on the leaves, stems, pods and seeds of the plant. The disease affects seed quality and can reduce yield by up to 45%, may be more in susceptible cultivars. CBB is very difficult to control due to seed-borne nature of the bacteria and its capacity to produce huge amounts of secondary inoculum.
    [Show full text]
  • Pluralibacter Gergoviae Als Spender- Oder Empfängerorganismus Gemäß § 5 Absatz 1 Gentsv
    Az. 45241.0205 Juni 2020 Empfehlung der ZKBS zur Risikobewertung von Pluralibacter gergoviae als Spender- oder Empfängerorganismus gemäß § 5 Absatz 1 GenTSV Allgemeines Pluralibacter gergoviae (früher: Enterobacter gergoviae [1]) ist ein Gram-negatives, fakultativ anaerobes, peritrich begeißeltes, stäbchenförmiges Bakterium aus der Familie der Enterobacteriaceae, das zuerst 1980 beschrieben wurde [2]. Es ist weltweit verbreitet und wurde aus klinischen Proben (Blut, Urin, Sputum, Stuhl, Hautabstriche, Ohrendrainage, nicht näher beschriebene Wunden, Abszesse, Lunge, Niere) sowie aus dem Darm eines Roten Baumwollkapselwurms, Wasserproben und Kosmetikprodukten isoliert [2–7]. Das Überleben in Kosmetikprodukten wird dadurch ermöglicht, dass P. gergoviae eine hohe Toleranz gegen Konservierungsmittel wie Benzoesäure und Parabenen aufweist [8]. Aufgrund dieser Toleranz ist P. gergoviae in der Vergangenheit mehrfach als mikrobielle Verunreinigung in Kosmetikprodukten aufgetreten, die daraufhin zurückgerufen werden mussten [9]. Im klinischen Kontext tritt P. gergoviae vergleichsweise selten als Krankheitserreger auf. Das Bakterium löst vor allem bei Immunkompromittierten Infektionen aus, die tödlich verlaufen können. Es verursachte Harnwegsinfektionen oder Infektionen der Operationswunde bei Empfängern von Nierentransplantaten [10], mehrere Sepsisfälle auf einer Neugeborenenstation, von denen die Mehrzahl Frühgeborene betrafen [3], und führte zu einem Septischen Schock bei einem Leukämie-Patienten [11]. Bei Immunkompetenten wurden eine Sepsis
    [Show full text]
  • CATALOGO GENERALE - Listino Prezzi 2020 2021 Chromart CATALOGOTERRENI GENERALE Listinocromogeni Prezzi 2021 - 2022 Per La Microbiologia Industriale
    Microbiologia Microbiologia Microbiologia Microbiologia Microbiologia Microbiologia CATALOGO GENERALE - Listino Prezzi 2020 2021 CATALOGO ChromArt CATALOGOTERRENI GENERALE ListinoCROMOGENI Prezzi 2021 - 2022 Per la Microbiologia Industriale Microbiologia Clinica e Industriale Ph: A. Geraci Microbiologia Clinica e Industriale Terreni cromogeni Rev. 02/2021 per l’isolamento e l’identificazione dei principali patogeni ed indicatori fecali negli alimenti, mangimi ed acque. Biolife Biolife ItalianaBiolife srl - VItalianaiale Monza srl - 272Viale 20128 Monza Milano272 20128 - Tel. 02Milano 25209.1 - Tel. 02- www 25209.1.biolifeitaliana.i - www.biolifeitaliana.it t Biolife Italiana srl - Viale Monza 272 20128 Milano - Tel. 02 25209.1 - www.biolifeitaliana.it t .biolifeitaliana.i www - 25209.1 02 l. Te - Milano 20128 272 Monza iale V - l sr Italiana Biolife CONDIZIONI GENERALI DI VENDITA PREZZI I prezzi segnati nei nostri listini si intendono Iva esclusa e sono comprensivi di imballo normale e spedizione con vettori con noi convenzionati. Gli imballi speciali e/o refrigerati saranno addebitati al costo. Le spedizioni con vettori scelti dal cliente saranno a carico di quest’ultimo. L’IVA (Imposta sul Valore Aggiunto) è sempre a carico del Committente nella misura di legge. ORDINI Gli ordini devono essere formulati per iscritto e verranno evasi rispettando le unità di confezioni indicate nel listino. Per evitare errori raccomandiamo di indicare sempre negli ordini il numero di codice e la denominazione di ciascun articolo nonché la quantità richiesta. È nostro diritto accettare, annullare e procrastinare in tutto o in parte ordini a seguito di sopravvenute impossibilità da parte nostra, dei nostri fornitori e dei vettori. Tali cause ci sollevano da ogni obbligo precedentemente assunto con l’accettazione dell’ordine.
    [Show full text]
  • Horizontal Gene Transfer Plays a Major Role in the Pathological Convergence of Xanthomonas Lineages on Common Bean Nicolas W
    Chen et al. BMC Genomics (2018) 19:606 https://doi.org/10.1186/s12864-018-4975-4 RESEARCHARTICLE Open Access Horizontal gene transfer plays a major role in the pathological convergence of Xanthomonas lineages on common bean Nicolas W. G. Chen1†, Laurana Serres-Giardi1†, Mylène Ruh1, Martial Briand1, Sophie Bonneau1, Armelle Darrasse1, Valérie Barbe2, Lionel Gagnevin3,4, Ralf Koebnik4 and Marie-Agnès Jacques1* Abstract Background: Host specialization is a hallmark of numerous plant pathogens including bacteria, fungi, oomycetes and viruses. Yet, the molecular and evolutionary bases of host specificity are poorly understood. In some cases, pathological convergence is observed for individuals belonging to distant phylogenetic clades. This is the case for Xanthomonas strains responsible for common bacterial blight of bean, spread across four genetic lineages. All the strains from these four lineages converged for pathogenicity on common bean, implying possible gene convergences and/or sharing of a common arsenal of genes conferring the ability to infect common bean. Results: To search for genes involved in common bean specificity, we used a combination of whole-genome analyses without a priori, including a genome scan based on k-mer search. Analysis of 72 genomes from a collection of Xanthomonas pathovars unveiled 115 genes bearing DNA sequences specific to strains responsible for common bacterial blight, including 20 genes located on a plasmid. Of these 115 genes, 88 were involved in successive events of horizontal gene transfers among the four genetic lineages, and 44 contained nonsynonymous polymorphisms unique to the causal agents of common bacterial blight. Conclusions: Our study revealed that host specificity of common bacterial blight agents is associated with a combination of horizontal transfers of genes, and highlights the role of plasmids in these horizontal transfers.
    [Show full text]
  • 2021 ECCMID | 00656 in Vitro Activities of Ceftazidime-Avibactam and Comparator Agents Against Enterobacterales
    IHMA In Vitro Activities of Ceftazidime-avibactam and Comparator Agents against Enterobacterales and 2122 Palmer Drive 00656 Schaumburg, IL 60173 USA Pseudomonas aeruginosa from Israel Collected Through the ATLAS Global Surveillance Program 2013-2019 www.ihma.com M. Hackel1, M. Wise1, G. Stone2, D. Sahm1 1IHMA, Inc., Schaumburg IL, USA, 2Pfizer Inc., Groton, CT USA Introduction Results Results Summary Avibactam (AVI) is a non-β- Table 1 Distribution of 2,956 Enterobacterales from Israel by species Table 2. In vitro activity of ceftazidime-avibactam and comparators agents Figure 2. Ceftazidime and ceftazidime-avibactam MIC distribution against 29 . Ceftazidime-avibactam exhibited a potent lactam, β-lactamase inhibitor against Enterobacterales and P. aeruginosa from Israel, 2013-2019 non-MBL carbapenem-nonsusceptible (CRE) Enterobacterales from Israel, antimicrobial activity higher than all Organism N % of Total mg/L that can restore the activity of Organism Group (N) %S 2013-2019 comparator agents against all Citrobacter amalonaticus 2 0.1% MIC90 MIC50 Range ceftazidime (CAZ) against Enterobacterales (2956) 20 Enterobacterales from Israel (MIC90, 0.5 Citrobacter braakii 5 0.2% Ceftazidime-avibactam 99.8 0.5 0.12 ≤0.015 - > 128 Ceftazidime Ceftazidime-avibactam organisms that possess Class 18 mg/L; 99.8% susceptible). Citrobacter freundii 96 3.2% Ceftazidime 70.1 64 0.25 ≤0.015 - > 128 A, C, and some Class D β- Cefepime 71.8 > 16 ≤0.12 ≤0.12 - > 16 16 . Susceptibility to ceftazidime-avibactam lactmase enzymes. This study Citrobacter gillenii 1 <0.1% Meropenem 98.8 0.12 ≤0.06 ≤0.06 - > 8 increased to 100% for the Enterobacterales Amikacin 95.4 8 2 ≤0.25 - > 32 14 examined the in vitro activity Citrobacter koseri 123 4.2% when MBL-positive isolates were removed Colistin (n=2544)* 82.2 > 8 0.5 ≤0.06 - > 8 12 of CAZ-AVI and comparators Citrobacter murliniae 1 <0.1% Piperacillin-tazobactam 80.4 32 2 ≤0.12 - > 64 from analysis.
    [Show full text]
  • In Vitro Activities of Aztreonam-Avibactam and Ceftazidime-Avibactam Against Less Commonly Encountered Gram-Negative Bacteria Co
    IHMA, Inc. In Vitro Activities of Aztreonam-avibactam and Ceftazidime-avibactam Against Less Commonly Encountered Gram-Negative 2122 Palmer Drive P1155 Schaumburg, IL 60173 USA Bacteria Collected During the ATLAS Global Surveillance Program 2012-2017 www.ihma.com M. Hackel1, G Stone2, B. deJonge3, D. Sahm1 1IHMA, Inc., Schaumburg IL, USA 2Pfizer Inc., Cambridge, MA USA 3Pfizer Inc., Cambridge MA, USA Introduction Results Results While antimicrobial susceptibility Table 1. Less commonly isolated gram-negative species Table 2. In vitro activity of ceftazidime-avibactam, aztreonam-avibactam and comparators against less commonly encountered gram-negative bacteria collected in 2012-2017 . ATM-AVI and CAZ-AVI showed MIC90 values from the ATLAS Global Surveillance Program 2012-2017 AZT-AVI CAZ-AVI CST* MEM TGC TZP LVX profiles have been well described in Organism N ranging from ≤0.015 to 0.5 mg/L and 0.06 to 1 %S MIC Range %S MIC Range %S MIC Range %S MIC Range %S MIC Range %S MIC Range %S MIC Range more common members of the 90 90 90 90 90 90 90 mg/L, respectively, against members of the Organism N Percent of total Acinetobacter nosocomialis 183 na 64 2 - >128 na 32 1 - >128 96.8 2 0.25 - >8 79.8 > 8 0.015 - >8 na 1 0.06 - 4 na > 128 ≤0.25 - >128 76.5 >4 0.06 - >8 Enterobacterales, notably Escherichia Enterobacterales (Table 2). 98.3% were coli and Klebsiella pneumoniae, and in Acinetobacter nosocomialis 183 5.1 Acinetobacter pittii 402 na 64 2 - >128 na 16 0.5 - >128 99.2 2 0.12 - 4 92.3 1 ≤0.06 - >8 na 1 0.03 - >8 na 64 ≤0.25 - >128 88.6 2 0.06 - >8 Citrobacter spp.
    [Show full text]
  • Pocket Guide to Clinical Microbiology
    4TH EDITION Pocket Guide to Clinical Microbiology Christopher D. Doern 4TH EDITION POCKET GUIDE TO Clinical Microbiology 4TH EDITION POCKET GUIDE TO Clinical Microbiology Christopher D. Doern, PhD, D(ABMM) Assistant Professor, Pathology Director of Clinical Microbiology Virginia Commonwealth University Health System Medical College of Virginia Campus Washington, DC Copyright © 2018 Amer i can Society for Microbiology. All rights re served. No part of this publi ca tion may be re pro duced or trans mit ted in whole or in part or re used in any form or by any means, elec tronic or me chan i cal, in clud ing pho to copy ing and re cord ing, or by any in for ma tion stor age and re trieval sys tem, with out per mis sion in writ ing from the pub lish er. Disclaimer: To the best of the pub lish er’s knowl edge, this pub li ca tion pro­ vi des in for ma tion con cern ing the sub ject mat ter cov ered that is ac cu rate as of the date of pub li ca tion. The pub lisher is not pro vid ing le gal, med i cal, or other pro fes sional ser vices. Any ref er ence herein to any spe cific com mer cial prod ucts, pro ce dures, or ser vices by trade name, trade mark, man u fac turer, or oth er wise does not con sti tute or im ply en dorse ment, rec om men da tion, or fa vored sta tus by the Ameri can Society for Microbiology (ASM).
    [Show full text]
  • Novel Viruses That Lyse Plant and Human Strains of Kosakonia Cowanii
    viruses Article Novel Viruses That Lyse Plant and Human Strains of Kosakonia cowanii Karel Petrzik 1,* ,Sára Brázdová 1 and Krzysztof Krawczyk 2 1 Biology Centre, Department of Plant Virology, Institute of Plant Molecular Biology, Czech Academy of Sciences, Branišovská 31, 370 05 Ceskˇ é Budˇejovice,Czech Republic; [email protected] 2 Department of Molecular Biology and Biotechnology, Institute of Plant Protection-National Research Institute, Władislawa W˛egorka20, 60-318 Pozna´n,Poland; [email protected] * Correspondence: [email protected]; Tel.: +420-387-775-549 Abstract: Kosakonia cowanii (syn. Enterobacter cowanii) is a highly competitive bacterium that lives with plant, insect, fish, bird, and human organisms. It is pathogenic on some plants and an opportunistic pathogen of human. Nine novel viruses that lyse plant pathogenic strains and/or human strains of K. cowanii were isolated, sequenced, and characterized. Kc166A is a novel kayfunavirus, Kc261 is a novel bonnellvirus, and Kc318 is a new cronosvirus (all Autographiviridae). Kc237 is a new sortsnevirus, but Kc166B and Kc283 are members of new genera within Podoviridae. Kc304 is a new winklervirus, and Kc263 and Kc305 are new myoviruses. The viruses differ in host specificity, plaque phenotype, and lysis kinetics. Some of them should be suitable also as pathogen control agents. Keywords: complete genome; bonnellvirus; sortsnevirus; cronosvirus; kayfunavirus; winklervirus; myovirus Citation: Petrzik, K.; Brázdová, S.; Krawczyk, K. Novel Viruses That 1. Introduction Lyse Plant and Human Strains of Kosakonia cowanii is a recently reclassified bacterial species [1] within the Enterobac- Kosakonia cowanii. Viruses 2021, 13, teriaceae family, previously known as Enterobacter cowanii [2].
    [Show full text]
  • From Genotype to Phenotype: Inferring Relationships Between Microbial Traits and Genomic Components
    From genotype to phenotype: inferring relationships between microbial traits and genomic components Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakult¨at der Heinrich-Heine-Universit¨atD¨usseldorf vorgelegt von Aaron Weimann aus Oberhausen D¨usseldorf,29.08.16 aus dem Institut f¨urInformatik der Heinrich-Heine-Universit¨atD¨usseldorf Gedruckt mit der Genehmigung der Mathemathisch-Naturwissenschaftlichen Fakult¨atder Heinrich-Heine-Universit¨atD¨usseldorf Referent: Prof. Dr. Alice C. McHardy Koreferent: Prof. Dr. Martin J. Lercher Tag der m¨undlichen Pr¨ufung: 24.02.17 Selbststandigkeitserkl¨ arung¨ Hiermit erkl¨areich, dass ich die vorliegende Dissertation eigenst¨andigund ohne fremde Hilfe angefertig habe. Arbeiten Dritter wurden entsprechend zitiert. Diese Dissertation wurde bisher in dieser oder ¨ahnlicher Form noch bei keiner anderen Institution eingereicht. Ich habe bisher keine erfolglosen Promotionsversuche un- ternommen. D¨usseldorf,den . ... ... ... (Aaron Weimann) Statement of authorship I hereby certify that this dissertation is the result of my own work. No other person's work has been used without due acknowledgement. This dissertation has not been submitted in the same or similar form to other institutions. I have not previously failed a doctoral examination procedure. Summary Bacteria live in almost any imaginable environment, from the most extreme envi- ronments (e.g. in hydrothermal vents) to the bovine and human gastrointestinal tract. By adapting to such diverse environments, they have developed a large arsenal of enzymes involved in a wide variety of biochemical reactions. While some such enzymes support our digestion or can be used for the optimization of biotechnological processes, others may be harmful { e.g. mediating the roles of bacteria in human diseases.
    [Show full text]
  • International Journal of Systematic and Evolutionary Microbiology (2016), 66, 5575–5599 DOI 10.1099/Ijsem.0.001485
    International Journal of Systematic and Evolutionary Microbiology (2016), 66, 5575–5599 DOI 10.1099/ijsem.0.001485 Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Mobolaji Adeolu,† Seema Alnajar,† Sohail Naushad and Radhey S. Gupta Correspondence Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Radhey S. Gupta L8N 3Z5, Canada [email protected] Understanding of the phylogeny and interrelationships of the genera within the order ‘Enterobacteriales’ has proven difficult using the 16S rRNA gene and other single-gene or limited multi-gene approaches. In this work, we have completed comprehensive comparative genomic analyses of the members of the order ‘Enterobacteriales’ which includes phylogenetic reconstructions based on 1548 core proteins, 53 ribosomal proteins and four multilocus sequence analysis proteins, as well as examining the overall genome similarity amongst the members of this order. The results of these analyses all support the existence of seven distinct monophyletic groups of genera within the order ‘Enterobacteriales’. In parallel, our analyses of protein sequences from the ‘Enterobacteriales’ genomes have identified numerous molecular characteristics in the forms of conserved signature insertions/deletions, which are specifically shared by the members of the identified clades and independently support their monophyly and distinctness. Many of these groupings, either in part or in whole, have been recognized in previous evolutionary studies, but have not been consistently resolved as monophyletic entities in 16S rRNA gene trees. The work presented here represents the first comprehensive, genome- scale taxonomic analysis of the entirety of the order ‘Enterobacteriales’.
    [Show full text]
  • Streptococcus Pneumoniae, Viridans Group, and 50/90 Streptococci (301) 0.0 41.5 90.4 98.7 100.0 Some Nonfermenters, and Fastidious Organisms Against E
    Contact Information: Michael D. Huband, BS In vitro Activity of Omadacycline and Comparators against Gram-Positive and -Negative Clinical Isolates JMI Laboratories 345 Beaver Kreek Centre, Suite A ECCMID 2018 (including resistant organism subsets) Collected in 2017 from Patients in European Medical Centres: North Liberty, IA 52317 http://paratekpharma Phone: (319) 665-3370 .com/media/1550 Fax: (319) 665-3371 Poster #P1822 SENTRY Surveillance Program Results /eccmid-2018-p1822 -sentry-2017-europe.pdf Email: [email protected] MD Huband, MA Pfaller, JM Streit, HS Sader, RK Flamm JMI Laboratories, North Liberty, Iowa, USA INTRODUCTION RESUlts (CONT.) Table 1 Antimicrobial activity of omadacycline against clinical isolates from patients in European medical centres during 2017 CONCLUSIONS (CONT.) No. of isolates at MIC (mg/L; cumulative %) Organism/organism No. of isolates at MIC (mg/L; cumulative %) • Omadacycline is an aminomethylcycline antibacterial for treating acute bacterial skin Organism/organism MIC MIC • Enterobacteriaceae including ESBL-phenotype isolates of E. coli (97.3% inhibited) • β-haemolytic streptococci (Streptococcus agalactiae, S. dysgalactiae, and MIC50 MIC90 a 50 90 group (no. of isolates) ≤0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 > a group (no. of isolates) ≤0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 > and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia e and K. pneumoniae (74.7% inhibited) were inhibited by ≤4 mg/L of omadacycline S. pyogenes) were very susceptible to omadacycline (MIC50/90 0.12/0.12 mg/L, Staphylococcus aureus 0 1 89 1,041 180 11 4 Enterobacteriaceae 0 56 726 886 623 292 164 123 68 21 (CABP) that recently completed Phase 3 clinical trials (oral and intravenous 0.12 0.25 1 8 highest MIC 0.5 mg/L) (1,326) 0.0 0.1 6.8 85.3 98.9 99.7 100.0 (2,959) 0.0 1.9 26.4 56.4 77.4 87.3 92.8 97.0 99.3 100.0 • Nonfermenters that included A.
    [Show full text]
  • Bacteria-Killing Type IV Secretion Systems
    fmicb-10-01078 May 18, 2019 Time: 16:6 # 1 REVIEW published: 21 May 2019 doi: 10.3389/fmicb.2019.01078 Bacteria-Killing Type IV Secretion Systems Germán G. Sgro1†, Gabriel U. Oka1†, Diorge P. Souza1‡, William Cenens1, Ethel Bayer-Santos1‡, Bruno Y. Matsuyama1, Natalia F. Bueno1, Thiago Rodrigo dos Santos1, Cristina E. Alvarez-Martinez2, Roberto K. Salinas1 and Chuck S. Farah1* 1 Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil, 2 Departamento de Genética, Evolução, Microbiologia e Imunologia, Instituto de Biologia, University of Campinas (UNICAMP), Edited by: Campinas, Brazil Ignacio Arechaga, University of Cantabria, Spain Reviewed by: Bacteria have been constantly competing for nutrients and space for billions of years. Elisabeth Grohmann, During this time, they have evolved many different molecular mechanisms by which Beuth Hochschule für Technik Berlin, to secrete proteinaceous effectors in order to manipulate and often kill rival bacterial Germany Xiancai Rao, and eukaryotic cells. These processes often employ large multimeric transmembrane Army Medical University, China nanomachines that have been classified as types I–IX secretion systems. One of the *Correspondence: most evolutionarily versatile are the Type IV secretion systems (T4SSs), which have Chuck S. Farah [email protected] been shown to be able to secrete macromolecules directly into both eukaryotic and †These authors have contributed prokaryotic cells. Until recently, examples of T4SS-mediated macromolecule transfer equally to this work from one bacterium to another was restricted to protein-DNA complexes during ‡ Present address: bacterial conjugation. This view changed when it was shown by our group that many Diorge P.
    [Show full text]